ArticleFrontiers in immunology2022

A Third Dose of an Inactivated Vaccine Dramatically Increased the Levels and Decay Times of Anti-SARS-CoV-2 Antibodies, but Disappointingly Declined Again: A Prospective, Longitudinal, Cohort Study at 18 Serial Time Points Over 368 Days.

Xian-Ming Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.